TheracosBio and BAMCO Africa, Inc. today announced they have partnered to bring BRENZAVVY® (bexagliflozin), an FDA-approved oral sodium-glucose cotransporter 2 (SGLT2) inhibitor for the treatment of ...
"The findings showed that in patients with deep diabetic foot ulcers, treatment with intact fish skin grafts was more effective than standard care, resulting in a higher proportion of healed wounds at ...
Foot ulcers develop in about 15% of the 25 million Americans living with diabetes and are a top cause of hospitalization. These ulcers can lead to serious complications, such as infection and ...
Around the world, there are half a billion adults living with diabetes, many of whom will develop foot ulcers. Across the ... necessary when the appropriate treatment measures are duly considered.